Advanced yolk sac tumor, neoadjuvant chemotherapy, primary surgery, cytoreduction, survival
Germline BRCA 1/2 mutations, Epithelial ovarian cancer (EOC), Cancer-predisposing genes (CPGs), Homologous recombination (HR) genes, Overall survival (OS) and progression-free survival (PFS)